TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO)
Clinical trial NCT03093701 · COMPLETED
Trial details
- NCT number
- NCT03093701
- Sponsor
- Taiwan Liposome Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-01
- Primary completion
- 2019-02-04
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.